Zanubrutinib Plus Obinutuzumab in Patients With Chronic Lymphocytic Leukemia and Follicular Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Zanubrutinib (BGB-3111) Plus Obinutuzumab in Patients With Chronic Lymphocytic Leukemia and Follicular Lymphoma
Blood Adv 2020 Oct 13;4(19)4802-4811, CS Tam, H Quach, A Nicol, X Badoux, H Rose, HM Prince, MF Leahy, R Eek, N Wickham, SS Patil, J Huang, R Prathikanti, A Cohen, R Elstrom, W Reed, J Schneider, IW FlinnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.